Cardiac Ablation

DEVICE3 trials

Sponsors

Abbott Medical Devices, Galaxy Medical, Inc.

Conditions

Atrial FibrillationCardiac ArrhythmiasHypertensionParoxysmal Atrial FibrillationPersistent Atrial Fibrillation

Unknown Phase

A Feasibility Study to Evaluate the Effect of Concomitant Renal Denervation and Cardiac Ablation on AF Recurrence

CompletedNCT01907828

Abbott Medical DevicesHypertension, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation

Start: 2014-04-15End: 2018-10-15Updated: 2020-05-22

EnSite Precision™ 2.0 Registry

CompletedNCT02757430

Abbott Medical DevicesCardiac Arrhythmias

Start: 2016-08-30End: 2017-07-15Updated: 2019-05-06

Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation

Galaxy Medical, Inc.Atrial Fibrillation

Start: 2020-09-28End: 2023-04-30Target: 200Updated: 2022-08-22

Related Papers

Pulsed Field Ablation Using Focal Contact Force–Sensing Catheters for Treatment of Atrial Fibrillation: 1-Year Outcomes of the ECLIPSE AF Study

Circulation Arrhythmia and Electrophysiology2024-12-196 citations

Pulsed field ablation using focal contact force-sensing catheters for treatment of atrial fibrillation: acute and 90-day invasive remapping results

EP Europace2023-06-0160 citations